Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.
Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.
Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs
Timely Host Response Diagnostics for SEPSIS and Pneumonia
*The Nanōmix eLab® S1 Panel for Critical Infection has received CE Mark; other assays in development and regulatory review.
The Company’s common shares begin trading on the OTC Market under the NNMX ticker symbol as of the opening of the Market today.
Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.
"We are excited to move forward under this new structure with Nanomix’s complete organization and assets..."
